Supply Chain
CEOs may keep their purchasing power and hospitals could see the increased use of telehealth stick around after the coronavirus is gone.
If the current pandemic continues much longer, acquiring needed ventilator medications will present long-term challenges for patient care.
Creative thinking will be needed to carve out the necessary critical care capacity to address the surge in COVID-19 patients.
Various hospital challenges are feeding off each other as three out of four hospitals treat patients with coronavirus symptoms, OIG report says.
Providers continue to face critical shortages of critical care staff, ventilators, masks and other personal protection equipment.
Half of U.S. physicians say they have treated a patient with COVID-19 symptoms, while three-quarters report not being able to test easily.
With COVID-19 spreading, Trump has suggested that the increase in demand for supplies may not be due solely to the virus.
The recommendations center on redirecting the supply of the drugs from retail pharmacy settings to the hospital/acute care environment.
The coronavirus is causing hospitals to ramp up for a surge of cases while having to give up elective procedures that sustain their revenue.
The Department of Defense is releasing up to 2,000 ventilators and is making available up to 5 million N95 face masks from reserves.